Embryoxite
Techstars '25Florida, US · 2 known investors
Embryoxite develops AI-powered, non-invasive embryo analysis that predicts IVF implantation success by analyzing embryo culture medium, alongside an IVF electronic medical record and clinic management platform. It serves fertility clinics and reproductive medicine specialists, offering predictive analytics for embryo selection and ovarian reserve assessment.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does Embryoxite do?
- Embryoxite develops AI-powered, non-invasive embryo analysis that predicts IVF implantation success by analyzing embryo culture medium, alongside an IVF electronic medical record and clinic management platform. It serves fertility clinics and reproductive medicine specialists, offering predictive analytics for embryo selection and ovarian reserve assessment.
- Who founded Embryoxite?
- Embryoxite was founded by Delfina Vilieri.
- Who are Embryoxite's investors?
- Embryoxite's investors include GRIDX, Techstars.
- Where is Embryoxite headquartered?
- Embryoxite is headquartered in Florida, US.